COURSE PREVIEWAbout this course
This course contains the use of artificial intelligence.
Every medicine on the market is watched, every day, by pharmacovigilance professionals — the people who collect adverse event reports, judge whether a drug caused harm, detect new safety signals in millions of records, and act before patients are hurt. Pharmacovigilance is one of the largest and most stable career fields in the pharmaceutical industry, and this course teaches you how it actually works, end to end.
You will start with the foundations: what pharmacovigilance is, the disasters that created it, and the definitions everything else depends on — adverse events, adverse reactions, seriousness, and SUSARs. Then you will go inside the global system: the FDA, EMA, Health Canada and MHRA, the ICH E2 guidelines, and the EU Good Pharmacovigilance Practices modules.
From there, the course becomes a working apprenticeship. You will follow an individual case safety report through intake, triage, MedDRA coding, seriousness and causality assessment, and narrative writing. You will learn aggregate reporting — PSURs, PBRERs, DSURs — and the 7-day and 15-day expedited reporting clocks that govern the industry. You will learn how signals are detected with disproportionality analysis, validated, prioritized, and turned into label changes, risk management plans, REMS, and additional monitoring.
The final sections cover the business of drug safety: the PSMF, the QPPV, audits and inspections, CAPA, vendor oversight, and where AI and automation genuinely help — inside safety databases like Argus and Veeva Vault Safety and in literature monitoring — and where they cannot replace human medical judgment. The course closes with a complete careers section: the roles, the employers, the CV keywords that get you shortlisted, the interview questions companies actually ask, and a 30-60-90 day plan for your first pharmacovigilance job.
No HTA, no filler — just the drug safety discipline as it is practiced in industry, taught in short, focused lectures.
What you'll learn
- Define and correctly use the core vocabulary of drug safety: AE, ADR, SAE, SUSAR, expectedness, listedness
- Explain how the global PV system works: FDA, EMA, Health Canada, MHRA, ICH E2A–E2E and the EU GVP modules
- Judge whether a report meets the four minimum criteria for a valid case
- Process an ICSR through the full workflow: intake, triage, coding, assessment, narrative, submission
- Assess seriousness against the six regulatory criteria and causality with WHO-UMC and Naranjo
- Code events in MedDRA, choosing the right LLT and avoiding the classic coding pitfalls
- Explain aggregate reports: PSUR/PBRER, DSUR and PADER, and the 7-day and 15-day expedited clocks
- Describe how signals are detected (PRR, ROR, EBGM), validated, prioritized and acted on
- Read a Risk Management Plan and explain risk minimization, REMS and additional monitoring
- Explain the PSMF, the QPPV’s responsibilities, and what happens in PV audits and inspections
- Judge where AI and automation help in PV — and where human medical review is non-negotiable
- Prepare for a PV career: role map, CV keywords, interview answers and a 30-60-90 day first-job plan
Before you begin
- No prior pharmacovigilance experience needed — the course starts from the foundations
- A background or interest in pharmacy, life sciences, nursing, medicine or clinical research is helpful but not required
- A computer with a web browser and internet connection
Who this is for
- Pharmacy, life-science and healthcare graduates who want a pharma industry career
- Clinical research professionals who want to move into drug safety
- Pharmacovigilance beginners preparing for their first case-processing role
- Working PV professionals who want the complete system picture, not just their one workflow
- Anyone preparing for pharmacovigilance job interviews at pharma companies or CROs
How do you feel about this course?
Share your reaction. Select one emoji to leave or update your rating.
Please wait 30 seconds to explore this course.
This course opens on an external website.
Join the conversation
Share a thought or question. No account required.
Be the first to share your thoughts.



